Insufficient scRNA-seq data for expression of MAGEB2 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 48% | 1.05 | 10 / 21 | 6% | 4.00 | 31 / 504 |
| esophagus | 34% | 1.17 | 495 / 1445 | 15% | 9.56 | 28 / 183 |
| skin | 28% | 0.97 | 504 / 1809 | 19% | 19.62 | 89 / 472 |
| lung | 22% | 0.68 | 130 / 578 | 16% | 10.19 | 185 / 1155 |
| adipose | 38% | 1.69 | 463 / 1204 | 0% | 0 | 0 / 0 |
| breast | 36% | 1.32 | 165 / 459 | 2% | 0.72 | 23 / 1118 |
| stomach | 28% | 0.73 | 101 / 359 | 8% | 4.70 | 23 / 286 |
| intestine | 31% | 0.89 | 302 / 966 | 4% | 1.14 | 22 / 527 |
| liver | 19% | 0.51 | 42 / 226 | 15% | 5.68 | 59 / 406 |
| spleen | 32% | 0.93 | 77 / 241 | 0% | 0 | 0 / 0 |
| ovary | 26% | 3.48 | 46 / 180 | 4% | 0.77 | 18 / 430 |
| prostate | 27% | 1.71 | 66 / 245 | 0% | 0.01 | 1 / 502 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 21.11 | 7 / 29 |
| brain | 23% | 0.67 | 614 / 2642 | 0% | 0.01 | 2 / 705 |
| adrenal gland | 21% | 0.59 | 53 / 258 | 2% | 4.12 | 5 / 230 |
| uterus | 16% | 0.52 | 28 / 170 | 5% | 5.79 | 21 / 459 |
| peripheral blood | 21% | 0.73 | 193 / 929 | 0% | 0 | 0 / 0 |
| heart | 20% | 0.53 | 171 / 861 | 0% | 0 | 0 / 0 |
| thymus | 19% | 0.97 | 121 / 653 | 0% | 0 | 0 / 605 |
| blood vessel | 17% | 0.42 | 231 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 17% | 0.74 | 137 / 803 | 0% | 0 | 0 / 0 |
| kidney | 16% | 0.40 | 14 / 89 | 1% | 0.44 | 10 / 901 |
| pancreas | 16% | 0.38 | 52 / 328 | 1% | 0.02 | 1 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.11 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAGEB2 |
| Protein name | Melanoma-associated antigen B2 (Cancer/testis antigen 3.2) (CT3.2) (DSS-AHC critical interval MAGE superfamily 6) (DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen) |
| Synonyms | |
| Description | FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. . |
| Accessions | O15479 ENST00000378988.5 |